Home Archives INOVIO Announces Proposed Public Offering INOVIO Announces Proposed Public OfferingApril 1, 2026 B PLYMOUTH MEETING, Pa., April 1, 2026 /PRNewswire/ — INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to… Login to continue reading Login Sign up for complimentary access Sign Up Now Close posteditor Articles: 13760 Previous Post CHIC 2026 Honors Landmark Deals and Financings at Annual Awards Gala Next Post Lockheed Martin-built Orion Spacecraft Sends Astronauts Moonward for the First Time in 53 Years
London Lip Clinic Reveals Lip Filler Trends Transforming Natural Aesthetic Outcomes in LondonApril 29, 2026
Yroc Consulting Emerges as a Leading Business Consulting Company in Lubbock Through AI-Driven Growth StrategiesApril 29, 2026
Ocean Plumbing and Air Expands AC Repair in Miami to Reduce Downtime and Restore Cooling FasterApril 29, 2026
BuildSubmarines.com and RFK Racing Bring Hands-On STEM Learning to the Talladega Fan ZoneApril 29, 2026